Bausch & Lomb Corp
BLCO- Exchange
- NYSE
- Industry
- Ophthalmic Goods
- SEC CIK
- 0001860742
In the last 90 days, Bausch & Lomb Corp insiders filed 0 open-market purchases and 2 sales; 99 institutions reported holding it in 13F filings for Q2 2026, worth $638.7M in total; 3 superinvestors hold it, including Icahn Capital and Oaktree Capital.
13F holders, Q4 2025
Institutional positions in Bausch & Lomb Corp as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 99
- +7 vs. Q3 2025
- Shares held
- 40.3M
- +1.18M (+3.0%) vs. Q3 2025
- Total value
- $688.2M
- +$98.5M (+16.7%) vs. Q3 2025
- New holders
- 21
- 29 more added
- Sold out
- 14
- 32 more reduced
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BLCO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 99 | $638.7M |
| Q1 2026 | 97 | $612.1M |
| Q4 2025 | 99 | $688.2M |
| Q3 2025 | 93 | $590.3M |
| Q2 2025 | 94 | $504.6M |
| Q1 2025 | 107 | $546.5M |
| Q4 2024 | 114 | $632.7M |
| Q3 2024 | 110 | $728.8M |
| Q2 2024 | 89 | $591.3M |
| Q1 2024 | 87 | $650.4M |
| Q4 2023 | 90 | $663.7M |
| Q3 2023 | 87 | $729.8M |
| Q2 2023 | 77 | $903.5M |
| Q1 2023 | 75 | $784.0M |
| Q4 2022 | 87 | $694.1M |
| Q3 2022 | 73 | $714.0M |
| Q2 2022 | 74 | $600.0M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Bausch & Lomb Corp; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −769,000−100.0% | Sold out |
| Sona Asset Management (US) LLC | 0 | $0 | 0.00% | −455,332−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −444,467−100.0% | Sold out |
| CastleKnight Management LP | 0 | $0 | 0.00% | −41,600−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −30,116−100.0% | Sold out |
| NJ State Employees Deferred Compensation Plan | 0 | $0 | 0.00% | −25,500−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −17,822−100.0% | Sold out |
| Fountainhead AM, LLC | 0 | $0 | 0.00% | −17,429−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −15,326−100.0% | Sold out |
| Vident Advisory, LLC | 0 | $0 | 0.00% | −12,339−100.0% | Sold out |
| Gruss & Co., LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,573−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −83−100.0% | Sold out |
| Synovus Financial Corp | – | – | – | – | Not filed |